← All investors
About
AstraZeneca's corporate venture activity centres on MedImmune Ventures, the wholly owned, evergreen venture arm of the biopharmaceutical group, alongside partnered China-focused funds with CICC. It makes equity investments in private biopharmaceutical, medical technology and healthcare companies, typically from Series A onward. AstraZeneca committed a further $100m to the unit in 2011.
Industries
BiotechMedTech
Stage focus
Series ASeries B
Geography
USEuropeChina
Notable investments
- Fusion Pharmaceuticals
Raising from AstraZeneca Ventures?
I've worked with founders across the industrial stack. If AstraZeneca Ventures is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan